Breaking News
Sort by:
Top Post
Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience
Rarity Bioscience announces a new strategic investment from Belgium-based Novalis Biotech. The investment is facilitated […]
Protai Adds $12 Million to Seed Round to Build an Oncology Drug Discovery Pipeline
Protai, a proteomics and AI-powered drug discovery startup revolutionizing the way new drugs are discovered, […]
Myosin Therapeutics Closes Seed Round to Continue Development of Innovative Therapies for Glioblastoma and Stimulant Use Disorder
Myosin Therapeutics, a biotechnology company leveraging its innovative platform technology to identify new molecular entities […]
Mediar Therapeutics Announces $105 Million Financing to Advance Portfolio of First-in-Class Fibrosis Therapies
Mediar Therapeutics, a biotechnology company advancing a portfolio of first-in-class therapies that halt and even […]
Teitur Trophics Raises €28M in Series A Financing to Advance the Development and Treatment for Neurodegenerative Diseases
Teitur Trophics, a biotech company dedicated to developing new treatments for patients suffering from neurodegenerative […]
Ambrx Raises $78 Million and Completes its ATM Program
Ambrx Biopharma today announced that it has completed net sales of approximately $78 million of […]
Allorion Therapeutics Raises $50 Million Series B Financing
Allorion Therapeutics, a biotech company focusing on next-generation precision medicine for oncology and autoimmune diseases, […]
Noema Pharma Raises CHF 103 Million (USD 112 Million) in Series B Financing Round led by Forbion and Jeito Capital
Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system (CNS) disorders, announced that […]
Prana Thoracic Announces Series A Financing
Prana Thoracic, a medical device company developing the first minimally invasive lung tissue excision tool […]
Chroma Medicine Secures $135M in Series B Financing to Advance Breakthrough Epigenetic Editing Technology
Chroma Medicine, a genomic medicine company pioneering single-dose epigenetic editing therapeutics, today announced the completion […]
Antiverse Raises Funding and Demonstrates Therapeutic Antibody Identification with AI-driven Drug Discovery Platform
Antiverse Ltd, a biotechnology company developing a computational antibody drug discovery platform, has announced the […]
- Nanoscope Therapeutics Announces Positive Topline Results from Phase 2b RESTORE Trial of MCO-010 for the Treatment of Retinitis Pigmentosa Read more
- Glyscend Therapeutics Appoints Biotech Industry Veteran Michael Wyzga to its Board of Directors Read more
- Trobix Bio Raises $3 Million from Chartered Group to Advance Precision Microbiome Oncology Therapeutics Read more
- Mathai Mammen to Join FogPharma as Chairman, President and Chief Executive Officer Read more
- Confo Therapeutics Enters into Collaboration Agreement with Daiichi Sankyo to Discover Novel Medicines for CNS Diseases Read more